Selvita S.A. (FRA:787)

Market Cap	135.30M +12.8%
Revenue (ttm)	83.79M +0.0%
Net Income	-849.66K
EPS	-0.05
Shares Out	n/a
PE Ratio	n/a
Forward PE	31.29
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	6.80
Previous Close	6.66
Day's Range	6.80 - 6.80
52-Week Range	6.50 - 11.05
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 17, 2026

About Selvita

Selvita S.A. provides drug discovery, drug development, and contract testing services in Poland. The company offers computer-aided drug design and artificial intelligence solutions, including structure-based drug design, virtual screening, and bioinformatics; medicinal and synthetic, analytical, and solid state chemistry, as well as process chemistry and scale up, and compound management and libraries; structural biology, fragment-based drug discovery, protein production, modification, and characterization; vitro assays and model, mechanistic a...

• Industry: Commercial Physical and Biological Research
• Founded: 2007
• Employees: 691
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 787

Financial Performance

Financial numbers in PLN

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Jun 26, 2026

Data Sources Report a data error